Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfadoxine | 5328 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | sulfadoxine | 5328 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | sulfadoxine | 5328 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | sulfadoxine | 5328 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | sulfadoxine | 5328 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | sulfadoxine | 5328 | drug-path |
| mTOR signaling pathway | R-HSA-165662 | map04150 | sulfadoxine | 5328 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | sulfadoxine | 5328 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulfadoxine | 5328 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | sulfadoxine | 5328 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | pyrimethamine | 10921 | drug-path |
| Non-homologous end-joining | R-HSA-5693571 | map03450 | pyrimethamine | 10921 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | pyrimethamine | 10921 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | ticlopidine | 5472 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | ticlopidine | 5472 | drug-path |
| Non-homologous end-joining | R-HSA-5693571 | map03450 | ticlopidine | 5472 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | cinchocaine | 3025 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | cinchocaine | 3025 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | cinchocaine | 3025 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | cinchocaine | 3025 | drug-path |